Username Password
S&P 500: 1,342.64 Change: +0.17%
geirs2
P&P Score: 95.68 | Points: 0.00 | Accuracy: 87.50 | Average Pick Score: 65.91   Annual Return: N/A  
Open
 
Closed
 
All
 
Commentary
BUY: AMYLIN PHARMACEUTICALS INC. (AMLN) Rating: 2
Start Price: $8.75
Points: +47.85
Created: 11/06/2008
Has a long acting version of their Byetta drug in testing stage for the treatment of diabetes. Will require injection once a week instead of 720 times a year. Should hit market within the next 3 years. Stock down from 50 to 8. Good long term speculation.

Want to comment on this post? Sign up now. It's FREE!
Already registered? Log In.

register
Sponsored Links